ANIMALCARE GROUP PLC
("Animalcare" or the "Company")
RESULT OF 2022 AGM AND CHANGES TO BOARD COMMITTEE COMPOSITION
7 June 2022. Animalcare Group plc (AIM: ANCR), the international animal health business, is pleased to announce that all the resolutions proposed at the Company's Annual General Meeting earlier today were duly approved by shareholders.
Changes to the Board Committees
The Remuneration and Nomination Committee report in the Company's 2022 annual report stated that membership of the Board Committees would be reviewed when a new Independent Non-Executive Director had been appointed and that it was anticipated that Marc Coucke would stand down from the Committee during the year. Following the appointment of Doug Hutchens and Sylvia Metayer as Independent Non-Executive Directors, and with Nick Downshire standing down from the Board following today's AGM, the Board has reviewed the composition of its Committees and agreed the following changes with immediate effect.
Sylvia Metayer will take over as Chair of the Audit and Risk Committee. Doug Hutchens will join the Remuneration and Nomination Committee and the Audit and Risk Committee. Marc Coucke will stand down from the Remuneration and Nomination Committee and Jan Boone will stand down from the Audit and Risk Committee.
Details of the votes received are available of the Company's website at: https://www.animalcaregroup.com/investors/agm
Enquiries:
| Animalcare Group plc | |
|
| Chris Brewster, Chief Financial Officer and Company Secretary | +44 (0)1904 487 687 communications@animalcaregroup.com |
|
| Stifel Nicolaus Europe Limited (Nominated Adviser & Joint Broker) | +44 (0)20 7710 7600 | |
| Ben Maddison Nicholas Harland Nick Adams |
| |
| Panmure Gordon (Joint Broker) Corporate Finance: Freddy Crossley/Emma Earl Corporate Broking: Rupert Dearden
| +44 (0)20 7886 2500 | |
About Animalcare
Animalcare Group plc is a UK AIM-listed international development-focused veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
For more information about Animalcare, please visit www.animalcaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.